Soliton, Inc. (SOLY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Houston, TX, United States. El CEO actual es Christopher C. Capelli.
SOLY tiene fecha de IPO 2019-02-19, 13 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
